Franklin Covey Co. (FC)

Q: What's priced into Franklin Covey Co. (FC) stock?

FC is valued at a substantial premium to peers, with a durable premium as the main valuation driver and an expectations gap of 0.15. That suggests demanding expectations are already reflected, even though the priced-in assessment is tagged stretched; the evidence does not show high fragility.

Q: What does the Franklin Covey Co. (FC) outlook hinge on?

The multi-year view depends on whether cost control can sustain profitability and whether revenue performance supports management’s outlook. A guidance cut or further labor-market weakness would be unfavorable, while continued strong results and higher guidance from sector bellwethers would support sector momentum. The evidence on these forward scenarios is conditional, not a confirmed trend.

NYSEConsumer StaplesEducation & Training ServicesSnapshot 2026-10-23

$18.68-1.32%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Franklin Covey Co.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-11-30
Revenue	—	67.52M
EPS	—	0.15
Annual ending 2027-08-31
Revenue	—	274.79M
EPS	—	0.985
Annual ending 2028-08-31
Revenue	—	275M
EPS	—	0

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EBITDA near $28M-$31M	Adjusted EBITDA stays close to $28 million to $31 million.	Under Pressure	adjusted EBITDA falls below $28 million in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Reaffirmed in 5 of last 5 quarters. Adjusted EBITDA guidance was maintained within $28 million to $33 million, recently narrowed to $28 million to $31 million. Despite some narrowing, management consistently emphasizes this target. The trajectory is stable with limited progress in expanding the range. Delivery assessment Oct 24, 2026
EPS growth and earnings beats	The company beat Q3 earnings with EPS of $0.27 despite a guidance cut.	Intact	EPS falls below $0.67 in next quarter	Diluted EPS: $0.27 per share FY2026-Q3; GAAP. Published target: EPS >= $0.67 in next quarter. Target period is not explicitly aligned with this observation. Source published Jul 7, 20260.27 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending May 31, 2026 Source: company_financial_results. Reference: 6dc5186e-48d0-4d61-938e-123aac080087. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain revenue near $260M-$267M	A primary condition in Franklin Covey Co.'s published investment case. The stated target is >= $260 million and <= $267 million.	Intact	revenue falls below $260 million or above $267 million in FY26	Revenue: $67.807M FY2026-Q3; GAAP. Published target: >= $260 million and <= $267 million. Target period is not explicitly aligned with this observation. Source published Jul 7, 202667,807,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending May 31, 2026 Source: company_financial_results. Reference: 6dc5186e-48d0-4d61-938e-123aac080087. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-08-31 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-01	Unavailable	Unavailable	2 / 1
2026-09-02	Unavailable	Unavailable	2 / 1
2026-09-03	Unavailable	Unavailable	2 / 1
2026-09-04	Unavailable	Unavailable	2 / 1
2026-09-05	Unavailable	Unavailable	2 / 1
2026-09-06	Unavailable	Unavailable	2 / 1
2026-09-07	Unavailable	Unavailable	2 / 1
2026-09-08	Unavailable	Unavailable	2 / 1
2026-09-09	Unavailable	Unavailable	2 / 1
2026-09-10	Unavailable	Unavailable	2 / 1
2026-09-11	Unavailable	Unavailable	2 / 1
2026-09-12	Unavailable	Unavailable	2 / 1
2026-09-13	Unavailable	Unavailable	2 / 1
2026-09-14	Unavailable	Unavailable	2 / 1
2026-09-15	Unavailable	Unavailable	2 / 1
2026-09-16	Unavailable	Unavailable	2 / 1
2026-09-17	Unavailable	Unavailable	2 / 1
2026-09-18	Unavailable	Unavailable	2 / 1
2026-09-19	Unavailable	Unavailable	2 / 1
2026-09-20	Unavailable	Unavailable	2 / 1
2026-09-21	Unavailable	Unavailable	2 / 1
2026-09-22	Unavailable	Unavailable	2 / 1
2026-09-23	Unavailable	Unavailable	2 / 1
2026-09-24	Unavailable	Unavailable	2 / 1
2026-09-25	Unavailable	Unavailable	2 / 1
2026-09-26	Unavailable	Unavailable	2 / 1
2026-09-27	Unavailable	Unavailable	2 / 1
2026-09-28	Unavailable	Unavailable	2 / 1
2026-09-29	Unavailable	Unavailable	2 / 1
2026-09-30	Unavailable	Unavailable	2 / 1
2026-10-01	Unavailable	Unavailable	2 / 1
2026-10-02	Unavailable	Unavailable	2 / 1
2026-10-03	Unavailable	Unavailable	2 / 1
2026-10-04	Unavailable	Unavailable	2 / 1
2026-10-05	Unavailable	Unavailable	2 / 1
2026-10-06	Unavailable	Unavailable	2 / 1
2026-10-07	Unavailable	Unavailable	2 / 1
2026-10-08	Unavailable	Unavailable	2 / 1
2026-10-09	Unavailable	Unavailable	2 / 1
2026-10-10	Unavailable	Unavailable	2 / 1
2026-10-11	Unavailable	Unavailable	2 / 1
2026-10-12	Unavailable	Unavailable	2 / 1
2026-10-13	Unavailable	Unavailable	2 / 1
2026-10-14	Unavailable	Unavailable	2 / 1
2026-10-15	Unavailable	Unavailable	2 / 1
2026-10-16	Unavailable	Unavailable	2 / 1
2026-10-17	Unavailable	Unavailable	2 / 1
2026-10-18	Unavailable	Unavailable	2 / 1
2026-10-19	Unavailable	Unavailable	2 / 1
2026-10-20	Unavailable	Unavailable	2 / 1
2026-10-21	Unavailable	Unavailable	2 / 1
2026-10-22	Unavailable	Unavailable	2 / 1
2026-10-23	Unavailable	Unavailable	2 / 1
2026-10-24	Unavailable	Unavailable	2 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	3	0	0
2026-06-01	3	0	0
2026-07-01	3	0	0
2026-08-01	3	0	0
2026-09-01	3	0	0
2026-10-01	3	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EBITDA near $28M-$31MPublished status: Under Pressure
EPS growth and earnings beatsDiluted EPS: $0.27 per share
Maintain revenue near $260M-$267MRevenue: $67.807M

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.6%Typical daily move · historical

Downside history

-45.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Franklin Covey Co. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

FC is a higher-risk, loss-making company with signs of a profitability turnaround, rather than an established durable compounder. The long-term thesis is on watch: management has made progress on costs, but recent financial performance trails its industry cohort and the overall signal has turned mixed.

What's priced into Franklin Covey Co.

FC is valued at a substantial premium to peers, with a durable premium as the main valuation driver and an expectations gap of 0.15. That suggests demanding expectations are already reflected, even though the priced-in assessment is tagged stretched; the evidence does not show high fragility.

What the fundamentals likely do

Near term, revenue rose from the second to the third quarter, while operating income improved and net income turned positive. Management has maintained its adjusted EBITDA guidance, but narrowed its revenue and EBITDA ranges, so progress remains limited and cautious. A guidance cut, weakening jobs data, or erratic earnings could weigh on execution; the stated miss probability is 34%, with a quiet watch tier.

What Franklin Covey Co. hinges on